Literature DB >> 1419902

Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc.

B C Armstrong1, G W Krystal.   

Abstract

The N-myc oncogene has been implicated in the pathogenesis of a number of human tumors, including childhood neuroblastoma and adult small cell lung cancer. We have isolated and characterized complementary DNA clones derived from a transcription unit, N-cym, located on the opposite DNA strand to N-myc, with extensive overlap existing between the 5' ends of the two transcription units. The N-cym gene, which can encode a 109-amino acid protein, is expressed during fetal development, as well as in tumor cell lines containing amplified N-myc loci, where it is expressed at very high levels. Although other examples of overlapping, opposite-strand eukaryotic genes exist, N-myc and N-cym are unique in that they appear to be coregulated in tumor cell lines under basal growth conditions and in response to the differentiating agent retinoic acid. This coregulation suggests that their protein products may be functionally interrelated during normal development and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419902

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  21 in total

1.  MYCNOS functions as an antisense RNA regulating MYCN.

Authors:  Nadia Vadie; Sheena Saayman; Alexandra Lenox; Amanda Ackley; Mathew Clemson; Jon Burdach; Jonathan Hart; Peter K Vogt; Kevin V Morris
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

2.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 3.  Role of endogenous antisense RNA in cardiac gene regulation.

Authors:  Hans Peter Luther
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

4.  A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.

Authors:  Gregory S Yochum; Ryan Cleland; Richard H Goodman
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

5.  Cell type-specific expression of endogenous cardiac Troponin I antisense RNA in the neonatal rat heart.

Authors:  Stefanie Voigtsberger; Holger Bartsch; Gert Baumann; Hans Peter Luther
Journal:  Mol Cell Biochem       Date:  2009-01-30       Impact factor: 3.396

6.  A novel intron element operates posttranscriptionally To regulate human N-myc expression.

Authors:  L E Sivak; G Pont-Kingdon; K Le; G Mayr; K F Tai; B T Stevens; W L Carroll
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 7.  New genes contribute to genetic and phenotypic novelties in human evolution.

Authors:  Yong E Zhang; Manyuan Long
Journal:  Curr Opin Genet Dev       Date:  2014-09-16       Impact factor: 5.578

8.  CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.

Authors:  X Zhao; D Li; J Pu; H Mei; D Yang; X Xiang; H Qu; K Huang; L Zheng; Q Tong
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

9.  Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

Authors:  Ben Beheshti; Ilan Braude; Paula Marrano; Paul Thorner; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

10.  Regulation of MYCN expression in human neuroblastoma cells.

Authors:  Joannes F M Jacobs; Hans van Bokhoven; Frank N van Leeuwen; Christina A Hulsbergen-van de Kaa; I Jolanda M de Vries; Gosse J Adema; Peter M Hoogerbrugge; Arjan P M de Brouwer
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.